Stakeholders want more early FDA communication options, shorter Q-Sub response timelines
Regulatory NewsFerdous Al-Faruque
Diagnostics/IVDsMedical DevicesRegulatory Intelligence/PolicySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)